Published 5 days ago • loading... • Updated 5 days ago
Aytu outlines $49M-$54M FY27 operating expense plan as it targets 66%-67% gross margin in Q4 FY27 (NASDAQ:AYTU)
Summary by Seeking Alpha
1 Articles
1 Articles
Aytu outlines $49M-$54M FY27 operating expense plan as it targets 66%-67% gross margin in Q4 FY27 (NASDAQ:AYTU)
Aytu BioPharma (AYTU) Q4 FY2026 earnings call recap: EXXUA script growth, revenue beat, positive EBITDA, FY2027 margin/OpEx outlook and risks—read now.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last Updated100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium






